- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05979987
UCLA Health Patient Health Maintenance Text Reminder July 2023
Study Overview
Status
Conditions
Detailed Description
UCLA Health will launch an initiative called My Action Plan which is an outreach effort targeting the primary care patients at UCLA who have an outstanding, clinically indicated primary care preventative care gap (e.g., overdue colorectal cancer screening, outstanding diabetes tests) and aims at encouraging patients to complete their overdue health maintenance measures.
At the beginning of each month, identified UCLA Health primary care patients will be enrolled in a trial the investigators have pre-registered under the title "UCLA Health Patient Health Maintenance Outreach Text Message" and randomized to receive one of four text messages informing them that they have overdue health maintenance measures and urging them to take action to complete these measures. These text messages will contain a link to their MyChart patient portal account, specifically linking them to a My Action Plan electronic letter that will contain a personalized list of outstanding preventive care items and actionable steps to complete the items.
In July 2023, if participants do not open their My Action Plan electronic letter within 7 days after the initial outreach, they will be enrolled in the trial described in the current pre-registration. Patients will be randomly assigned in a 1:1:1:1 ratio to receive one of four text reminders 2 weeks after the initial outreach message. Additionally, within each text-reminder arm, patients will be randomized to one of three time slots for getting the reminder. The investigators will examine patients' interaction with these reminders and how that ultimately translates to them completing their indicated health maintenance measures.
The UCLA Department of Medicine (DOM) intends to roll out this QI initiative at the beginning of the 2023 calendar year and continue it for a span of at least 12 months. Each month, the initiative targets patients whose birthday falls into that month. This proposed trial will run for one month (July 2023).
Analysis Plan:
The investigators will utilize patient-level ordinary least squares (OLS) estimation, with statistical inferences based on model-robust standard errors. The primary model term will be indicator variables for arm assignment.
The analysis will adjust for sex, age, race/ethnicity, indicators for screenings/tests that patients are due for, and whether patients have upcoming primary care appointments. Missing covariate values will be handled by including 'unknown' indicators, along with mean imputation for quantitative covariates.
The investigators will first compare Arm 2 with Arm 1 to test the effect of encouraging patients to read the story about a patient whose life was saved by preventive screening.. If the difference is significant in an outcome measure, the investigators will then compare Arms 3 and 4 with Arms 1 and 2 to shed light on why Arm 2 differs from Arm 1.
Exploratory analyses will investigate heterogeneous treatment effects of Arm 2 (vs. Arm 1) by patients' gender, age, race/ethnicity, history of cancer and other pre-existing conditions, family cancer history, past adherence to screenings/tests that are included in the My Action Plan Initiative, past receipt of influenza vaccination, frequency of doctor visits.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90095
- UCLA Health Department of Medicine, Quality Office
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Empaneled to UCLA Health DOM Primary Care
- Has at least one overdue health maintenance measure that the My Action Plan initiative focuses on
- Has an active MyChart status
- Can accept SMS messages from UCLA Health
- Has not opened the My Action Plan electronic letter within 7 days of initial outreach
- Has a July Birthday
Exclusion Criteria:
- Under the age of 18
- Deceased patients
- Hospice patients
- Has opted out electronic communication (bulk messages, email, and/or text)
- For the final analysis, the investigators will further exclude patients who have scheduled appointments for all screenings/tests or completed all screenings/tests prior to the date when they are supposed to receive the reminder from this trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Control Reminder
Eligible, randomized participants will receive a generic text message reminding them to close their outstanding health gap.
|
The investigators will send randomized participants an SMS reminder encouraging them to click the provided link and close their outstanding, overdue preventive care measures. The provided link will take them to their MyChart login page; after logging in, they would see their personalized My Action Plan Letter detailing their personalized, overdue preventive care measures. |
Experimental: Anecdote-based Reminder
Eligible, randomized participants will receive a text message reminding them to close their outstanding health gap.
This message will contain an anecdote of a patient whose cancer was caught early through similar, recommended preventive screenings.
The message prompts patients to click on a link to read the story about the patient.
|
The investigators will send randomized participants an SMS reminder encouraging them to click the provided link and close their outstanding, overdue preventive care measures. The provided link will take them to their MyChart login page; after logging in, they would see their personalized My Action Plan Letter detailing their personalized, overdue preventive care measures.
The message will contain an anecdote of a patient whose cancer was caught early through similar, recommended preventive screenings.
The message prompts patients to click on a link to read the story about the patient.
|
Experimental: Anecdote-based Reminder without link
Eligible, randomized participants will receive a text message reminding them to close their outstanding health gap.
This message will contain an anecdote of a patient whose cancer was caught early through similar, recommended preventive screenings.
The message won't contain a link to the story, but it will briefly describe the story.
|
The investigators will send randomized participants an SMS reminder encouraging them to click the provided link and close their outstanding, overdue preventive care measures. The provided link will take them to their MyChart login page; after logging in, they would see their personalized My Action Plan Letter detailing their personalized, overdue preventive care measures.
The message will contain a link to an anecdote of a patient whose cancer was caught early through similar, recommended preventive screenings.
The message won't contain a link to the story, but it will briefly describe the story.
|
Experimental: Research-based Reminder
Eligible, randomized participants will receive a text message reminding them to close their outstanding health gap.
This message will mention that research has shown promptly closing health gaps saves lives.
The message will contain a link to an official website that supports the statement.
|
The investigators will send randomized participants an SMS reminder encouraging them to click the provided link and close their outstanding, overdue preventive care measures. The provided link will take them to their MyChart login page; after logging in, they would see their personalized My Action Plan Letter detailing their personalized, overdue preventive care measures.
This message will mention that research has shown promptly closing health gaps saves lives.The message will contain a link to an official website that supports the statement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Opening link within SMS Text message
Time Frame: 1 week after getting the reminder
|
Percentage of participants across the different reminder arms who click on the link in the reminder message
|
1 week after getting the reminder
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MyChart letter opened
Time Frame: 1 week after getting the reminder
|
Percentage of participants across the different arms who open their personalized My Action Plan letter on MyChart
|
1 week after getting the reminder
|
Direct scheduling appointment rate
Time Frame: 2 weeks after getting the reminder
|
Rate of which eligible participants directly schedule an appointment for diabetic retinal exams, diabetes education, or breast cancer screening in order to complete these overdue screening/test(s).
These screenings/tests have dedicated appointment resources that people can directly schedule for.
|
2 weeks after getting the reminder
|
Rate of taking action for one overdue screening/test
Time Frame: 2 weeks after getting the reminder
|
Rate of which participants schedule an appointment to complete their overdue screening/test or start the online tool for colorectal screening
|
2 weeks after getting the reminder
|
Completion rate of one screening/test
Time Frame: 6 months after getting the initial outreach text message
|
Rate of completion of at least one screening/test within the observation window.
|
6 months after getting the initial outreach text message
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MAPreminder3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceActive, not recruitingType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
Taichung Veterans General HospitalNational Health Research Institutes, TaiwanRecruitingDiabetes Complications | Type 2 Diabetes | Maturity-Onset Diabetes of the Young (MODY)Taiwan
-
Oregon State UniversitySanofiCompletedType I or Type II Diabetes (Excludes Gestational Diabetes)
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
University of RoehamptonRecruitingType2 Diabetes Mellitus | Pre DiabetesUnited Kingdom
Clinical Trials on Reminder of preventive care measures
-
University of California, Los AngelesUCLA David Geffen School of Medicine; UCLA Health Department of MedicineNot yet recruitingDiabetes | Cancer | Health Maintenance
-
University of California, Los AngelesUCLA Department of Medicine; The David Geffen School of MedicineEnrolling by invitationDiabetes | Cancer | Health MaintenanceUnited States
-
Fundación Instituto de Estudios de Ciencias de...Baxter Healthcare Corporation; Instituto de Investigación Biomédica de SalamancaCompletedProlonged Air Leak | Lung ResectionSpain
-
University of the PhilippinesWithdrawnCOVID-19Philippines
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHealthy SubjectUnited States
-
University Hospital, BordeauxCompletedRespiratory Failure | Chest InjuriesFrance
-
Virginia Commonwealth UniversityAgency for Healthcare Research and Quality (AHRQ)CompletedPreventionUnited States
-
Hospital de GranollersCompletedColorectal Neoplasms | Surgical Wound InfectionSpain
-
Children's Hospital of PhiladelphiaCenters for Disease Control and PreventionCompletedStress Disorders, PosttraumaticUnited States
-
Southwest Oncology GroupPatient-Centered Outcomes Research Institute; National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Febrile Neutropenia | Stage 0 Breast Cancer | Stage IV Non-Small Cell Lung Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast... and other conditionsUnited States, Puerto Rico